Daniel DeNeui is an esteemed entrepreneur and executive with a comprehensive strategic planning, business development, and executive sales coaching background. His profound understanding of human behavior, psychology, and public speaking expertise have allowed him to successfully establish and grow multiple multi-million dollar businesses, starting with limited initial capital.
As the CEO of EVEXIAS Health Solutions®, he is at the forefront of medical wellness, driving initiatives that restore passion to healthcare practices and enhance the quality of patient care. His leadership has been pivotal in redefining approaches to medicine by integrating innovative training and treatment solutions.
Working closely with his spouse, he leads the strategic vision for the EVEXIAS-FarmaKeio organization, focusing on expanding access to transformative educational and therapeutic services. Since taking the helm in 2015, his diverse background in science and business has enabled significant enhancements in the company’s offerings, including developing the EvexiPEL® Method, PeptideSolutions™, and NutraceuticalSolutions™.
At EVEXIAS, Daniel is committed to crafting personalized wellness plans that employ an integrative and functional approach, addressing the root causes of health issues rather than just symptoms. These plans often focus on managing hormone imbalances with innovative therapies such as bioidentical hormone replacement therapy and advanced nutraceutical supplements tailored to the individual needs of patients.
Under his leadership, the company has also embraced technological advances to improve patient care and practitioner education. In 2022, Daniel launched EVEXIAS Online, a cutting-edge platform that supports healthcare practitioners in their continuous education, allowing them to share insights, review complex cases, and access extensive educational materials. In early 2023, he managed the largest practitioner training event to date, enhancing skills in hormone therapy applications.
Before his current role, he held executive positions at Asperio Labs and BioTE Medical, focusing on hormone optimization and healthy aging. His earlier career also included leadership roles at Independent Producers of America and Cornerstone America, where he developed and executed strategies that significantly expanded business operations.
Daniel DeNeui’s educational journey in organic chemistry at Clemson University has provided a strong scientific foundation for his professional endeavors. Beyond his business and healthcare achievements, he is passionately involved in philanthropy, supporting various charities that help families navigate unexpected life challenges.
